Calamos Nasdaq-100 Structured Alt Protection ETF - MarchCPNM

CPNM is a listed ETF that trades under a Nasdaq ticker and promises “structured alternative protection” while charging 0.85% per year to hold a Nasdaq-100 basket with a side of option overlays few investors will ever unpack. The fund’s existence is a reminder that “protection” in finance often means “pay someone to absorb your pain at a fixed price,” and 0.85% is the pain’s hourly rate. The ticker itself is sleek-CPNM-while the prospectus is not, because when you dig into the structure you find a trust deed that reads like a legal document written by someone who once watched a lawyer thriller. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/cpnm)

The ETF’s mandate is to track the Nasdaq-100 with a “structured alternative protection” wrapper, which in plain English means it buys the index notes and sells options to a counterparty so the fund can claim it has “hedged” the downside-except the counterparty is usually a bank, and banks have a habit of charging for the privilege of hedging against their own balance-sheet risk. The 0.85% expense ratio is not a typo; it’s the annual toll you pay to sit inside a structure that may or may not protect you when the Nasdaq-100 drops. The fund’s AUM is modest, the liquidity thin, and the marketing sells “downside buffer” while the filing trail sells “complexity at scale.” (source: SEC EDGAR fund search for CPNM, https://www.sec.gov/edgar/search/#/q=CPNM)

What CPNM actually holds is a Nasdaq-100 index tracking basket plus a short option overlay written by a bank counterparty, and the filing trail is filed with the SEC under the fund’s series trust. The fund’s expense ratio is 0.85%, the management fee is embedded in that figure, and the brokerage costs are separate-though the filing trail does not itemise them in a way that would make a compliance officer blush. The fund’s AUM and liquidity are visible on Nasdaq’s listing page, but the real liquidity sits with market-makers and the counterparty bank, not with retail wallets. (source: SEC EDGAR fund search for CPNM, https://www.sec.gov/edgar/search/#/q=CPNM)

The fund’s chart route is available on Nasdaq, and the mechanism is simple: buy CPNM, pay 0.85% per year, hope the Nasdaq-100 does not crash, and trust that the counterparty bank does not walk away when it does. The structure is not new; it is a repackaged version of what banks sold in 2008 under names like “principal-protected notes,” except this time the wrapper is an ETF and the fee is transparent but relentless. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/cpnm)

What changed today is nothing the evidence names: no earnings, no filing amendments, and no SEC comment letters appear in the source rail. The fund’s price moves with the Nasdaq-100 and the option overlay, but the ETF wrapper hides the mechanics from plain sight. The fund’s AUM and liquidity are visible on Nasdaq and in the FINRA analyser, but the real liquidity is the secondary market-thin, dealer-quoted, and priced by the same banks that sold the protection. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

What remains unproven is whether the 0.85% expense ratio is justified by the level of downside protection delivered, and whether the counterparty bank’s credit risk is materially different from the Nasdaq-100 risk itself. The fund’s filing trail does not supply a backtest of the “protection” under stressed Nasdaq-100 scenarios, and the marketing does not benchmark the option overlay against a simple put-protected Nasdaq-100 strategy. Until the fund publishes that comparison, the wrapper’s value is an act of faith-and a fee. Evidence that would deepen the file: a backtest under 2022-style Nasdaq-100 drawdowns, a breakdown of brokerage and option costs, or a third-party credit assessment of the counterparty bank. (source: SEC EDGAR fund search for CPNM, https://www.sec.gov/edgar/search/#/q=CPNM)